These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The changes in mycolic acid structures caused by hadC mutation have a dramatic effect on the virulence of Mycobacterium tuberculosis. Slama N; Jamet S; Frigui W; Pawlik A; Bottai D; Laval F; Constant P; Lemassu A; Cam K; Daffé M; Brosch R; Eynard N; Quémard A Mol Microbiol; 2016 Feb; 99(4):794-807. PubMed ID: 26538472 [TBL] [Abstract][Full Text] [Related]
5. IQG-607 abrogates the synthesis of mycolic acids and displays intracellular activity against Mycobacterium tuberculosis in infected macrophages. Rodrigues-Junior VS; dos Santos Junior AA; Villela AD; Belardinelli JM; Morbidoni HR; Basso LA; Campos MM; Santos DS Int J Antimicrob Agents; 2014 Jan; 43(1):82-5. PubMed ID: 24139881 [TBL] [Abstract][Full Text] [Related]
6. Exocarpic acid inhibits mycolic acid biosynthesis in Mycobacterium tuberculosis. Koch M; Bugni TS; Sondossi M; Ireland CM; Barrows LR Planta Med; 2010 Oct; 76(15):1678-82. PubMed ID: 20506078 [TBL] [Abstract][Full Text] [Related]
7. [Biosynthesis and regulation of mycolic acids in Mycobacterium tuberculosis--a review]. Luo H; Pang L; Xie J Wei Sheng Wu Xue Bao; 2012 Feb; 52(2):146-51. PubMed ID: 22586991 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological aspects of mycolic acids: an important target against Mycobacterium tuberculosis. de Souza MV; Ferreira Mde L; Pinheiro AC; Saraiva MF; de Almeida MV; Valle MS ScientificWorldJournal; 2008 Jul; 8():720-51. PubMed ID: 18677428 [TBL] [Abstract][Full Text] [Related]
9. Isoniazid activity is terminated by bacterial persistence. Mitchison DA; Jindani A; Davies GR; Sirgel F J Infect Dis; 2007 Jun; 195(12):1871-2; author reply 1872-3. PubMed ID: 17492605 [No Abstract] [Full Text] [Related]
10. Persistence, not resistance, is the cause of loss of isoniazid effect. Wallis RS; Palaci M; Eisenach K J Infect Dis; 2007 Jun; 195(12):1870-1; author reply 1872-3. PubMed ID: 17492604 [No Abstract] [Full Text] [Related]
11. Structure, function and biogenesis of the mycobacterial cell wall. Brennan PJ; Besra GS Biochem Soc Trans; 1997 Feb; 25(1):188-94. PubMed ID: 9056869 [No Abstract] [Full Text] [Related]
12. Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis. Sacchettini JC; Rubin EJ; Freundlich JS Nat Rev Microbiol; 2008 Jan; 6(1):41-52. PubMed ID: 18079742 [TBL] [Abstract][Full Text] [Related]
13. Synergistic Interactions of MmpL3 Inhibitors with Antitubercular Compounds Li W; Sanchez-Hidalgo A; Jones V; de Moura VC; North EJ; Jackson M Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28115355 [TBL] [Abstract][Full Text] [Related]
15. The mechanism of isoniazid killing: clarity through the scope of genetics. Vilchèze C; Jacobs WR Annu Rev Microbiol; 2007; 61():35-50. PubMed ID: 18035606 [TBL] [Abstract][Full Text] [Related]